Related Experiment Video
Updated: Apr 30, 2026

Scanning Skeletal Remains for Bone Mineral Density in Forensic Contexts
Published on: January 29, 2018
Thalassemia bone disease: a 19-year longitudinal analysis.
Phillip Wong1, Peter J Fuller, Matthew T Gillespie
1Prince Henry's Institute of Medical Research, Clayton, Australia; Department of Endocrinology, Monash Health, Clayton, Australia; Department of Medicine, Monash University, Clayton, Australia.
Thalassemia patients experience significant bone mineral density loss, particularly at the femoral neck. Males with beta-thalassemia show greater bone loss and fracture risk, suggesting higher hemoglobin targets may be beneficial.
Area of Science:
- Hematology
- Endocrinology
- Osteology
Background:
- Thalassemia is an inherited blood disorder causing ineffective red blood cell production.
- Severe thalassemia necessitates chronic transfusions, leading to complications like iron overload and hormonal issues.
- These complications contribute to bone deformities and reduced bone mineral density (BMD).
Purpose of the Study:
- To investigate the longitudinal changes in BMD in transfusion-dependent thalassemia patients.
- To identify risk factors associated with bone loss in this population.
- To determine optimal monitoring sites for BMD in thalassemia patients.
Main Methods:
- A 19-year retrospective longitudinal study of 277 transfusion-dependent thalassemia subjects.
- Dual-energy X-ray absorptiometry (DXA) used to assess BMD at lumbar spine, femoral neck, and total body.
- Linear mixed-model analysis to evaluate BMD changes and associated risk factors.
Main Results:
- Significant longitudinal decline in BMD observed at the femoral neck (FN) and total body (TB).
- FN Z-score decline was more pronounced in males and accelerated in recent years, coinciding with a switch in iron chelator therapy.
- Higher hemoglobin levels correlated positively with better BMD at the TB and lumbar spine.
Conclusions:
- The femoral neck is the preferred site for monitoring BMD in thalassemia patients.
- Male patients with beta-thalassemia exhibit greater BMD loss and fracture risk.
- Higher hemoglobin targets may mitigate BMD decline; deferasirox's role in bone loss requires further investigation.
Related Concept Videos
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Longitudinal Research
Changes in the Appendicular Skeleton with Age
Initially, the limb buds consist of a core of mesenchyme covered by a layer of ectoderm. The ectoderm at the end of the limb bud thickens to form a narrow crest called the apical ectodermal ridge. This ridge stimulates the underlying...
Longitudinal Studies

